Clinical trialNCT00822172CompletedPhase 4Interventional

Evaluation of Cilostazol in Combination With L-Carnitine

SponsorColorado Prevention CenterEnrollment164Intermittent ClaudicationPeripheral Arterial DiseasePeripheral Vascular Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to see how safe and effective L carnitine taken with cilostazol is compared to placebo taken with cilostazol for people with intermittent claudication. A second purpose of the study is to see if L-carnitine is absorbed into the blood stream.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Neil Goldenberg, MD, PhD
University of Colorado Heather Sciences Center
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Internal Medicine Physicians Associates
Phoenix, Arizona, United States
Tatum Ridge Internal Medicine
Phoenix, Arizona, United States
Central Arkansas Veteran'S Healthcare System
Little Rock, Arkansas, United States
Va Palo Alto Health Care System
Palo Alto, California, United States
Sacramento Heart and Vascular Research Center
Sacramento, California, United States
University of California at Davis Vascular Center
Sacramento, California, United States
Apex Research Institute
Santa Ana, California, United States
Aurora Denver Cardiology Associates
Aurora, Colorado, United States
Aurora Denver Cardiology Associates
Denver, Colorado, United States
Pensacola Research Consultants, Inc.
Pensacola, Florida, United States
Dmi Healthcare Group, Inc.
Pinellas Park, Florida, United States
Meridian Research
St. Petersburg, Florida, United States
Ochsner Medical Center
New Orleans, Louisiana, United States
Hpv Heart, Pa
Columbia, Maryland, United States
University of Massachusetts Medical Center
Worcester, Massachusetts, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
University of Rochester Medical Center
Rochester, New York, United States
Durham Va-Medical Center
Durham, North Carolina, United States
Radiant Research, Inc
Columbus, Ohio, United States
Jobst Vascular Center
Toledo, Ohio, United States
Clinical Trials of Texas, Inc.
San Antonio, Texas, United States
Peripheral Vascular Associates
San Antonio, Texas, United States
Radiant Research- Salt Lake City
Salt Lake City, Utah, United States
Beloit Clinic Research Office
Beloit, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cilostazol →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2008
Primary completion: 30 Nov 2010
Completion: 31 Dec 2010
Last update posted: 29 Nov 2019
Registered enrollment: 164
Registry id: NCT00822172

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.